Herman Gist MD in Lanham, Maryland

Additional Medical Specialties Include:
CARDIOVASCULAR DISEASE (CARDIOLOGY), INTERNAL MEDICINE

Medical School: North Carolina Medical School
Graduation Year: 1986
The Primary Medical Specialty for Herman Gist MD is listed as: Interventional Cardiology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 38
PAC (PECOS ID)#: 2466448113
NPI #: 1275528234
NPI Created On: 09/15/2005
NPI Last Updated Listed as: 03/02/2011
Primary Taxonomy Code: 207RC0000X

URL not found for state: DC licensing board.
License Number:
MD20174
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• CareFirst BlueChoice, Inc.
• Group Hospitalization and Medical Services Inc.
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English,Spanish, Spanish.

Services and Procedures include:

1. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
2. Routine ekg using at least 12 leads including interpretation and report
3. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report
4. Remote evaluations of heart rhythm monitor system implanted under skin with qualified health care professional analysis, review, and report, up to 30 days
5. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
6. Anti-clotting management for patient taking warfarin
7. New patient office or other outpatient visit, typically 45 minutes
8. New patient office or other outpatient visit, typically 60 minutes
9. Established patient office or other outpatient visit, typically 15 minutes
10. Established patient office or other outpatient, visit typically 25 minutes
11. Established patient office or other outpatient, visit typically 40 minutes
12. Initial hospital inpatient care, typically 70 minutes per day
13. Technetium tc-99m sestamibi, diagnostic, per study dose
14. Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec
15. Injection, regadenoson, 0.1 mg